DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

100 Afleveringen

1. Key Factors for Choosing the Right CDMO

   Gepubliceerd: 28-8-2023
2. Strategies to Maximize Product Value Amid Loss of Exclusivity in the Pharmaceutical Industry

   Gepubliceerd: 21-8-2023
3. Unsuccessful Regulatory Filings for Biosimilar Approval: A Comprehensive Review

   Gepubliceerd: 15-8-2023
4. Drug Patent Reports now available on Amazon

   Gepubliceerd: 14-8-2023
5. Artificial Intelligence and Machine Learning in Drug Discovery and Development

   Gepubliceerd: 10-8-2023
6. Prevalence and timing of authorized generics in the US market

   Gepubliceerd: 8-8-2023
7. Insights into Shifting Dynamics: Orange Book and Biologic PTAB Trends

   Gepubliceerd: 7-8-2023
8. The Evolution of Reverse Payment Cases: Courts and Agencies’ Approaches in Pharma Litigation

   Gepubliceerd: 5-8-2023
9. Understanding the Impact of Authorized Generics on Drug Pricing: The Entacapone Case Study

   Gepubliceerd: 2-8-2023
10. Review of 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020: A Focus on Intellectual Property and Regulatory Considerations

    Gepubliceerd: 28-7-2023
11. DrugPatentWatch reveals NIH funding for patents

    Gepubliceerd: 27-7-2023
12. Filing Strategies for Maximizing Pharma Patents

    Gepubliceerd: 25-7-2023
13. DrugChatter Featured Questions

    Gepubliceerd: 8-6-2023
14. DrugChatter.com: AI Chat for Biopharmaceutical Drug Insights

    Gepubliceerd: 22-5-2023
15. NPR and DrugPatentWatch – Can drug injector pens be swapped?

    Gepubliceerd: 16-5-2023
16. Utilizing 505(b)(2) Regulatory Pathway for New Drug Applications: An Overview on the Advanced Formulation Approach and Challenges

    Gepubliceerd: 19-4-2023
17. Social Return on Investment

    Gepubliceerd: 6-9-2022
18. CDCDB: A large and continuously updated drug combination database

    Gepubliceerd: 7-6-2022
19. DrugPatentWatch named “Best of the Web” by Genetic Engineering News

    Gepubliceerd: 2-5-2022
20. The value of method of use patent claims in protecting your therapeutic assets

    Gepubliceerd: 5-4-2022